Targeting the IL33–NLRP3 axis improves therapy for experimental cerebral malaria
Patrick Strangward, M. Haley, M. G. Albornoz, Jack Barrington, Tovah N. Shaw, Rebecca S Dookie, L. Zeef, S. M. Baker, E. Winter, T. Tzeng, D. Golenbock, S. Cruickshank, S. Allan, A. Craig, F. Liew, D. Brough, K. Couper
Proceedings of the National Academy of Sciences of the United States of America